Application of mt-nd6 as a new target in the diagnosis and treatment of metabolic syndrome
A MT-ND6, material technology, applied in the fields of biology and medicine, has achieved important development value, good application prospects, and easy operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050] Methylation of MT-ND6 gene can be used as a biomarker for early clinical screening, diagnosis and prognosis of obesity, type 2 diabetes and other metabolic syndromes and their complications based on insulin resistance
[0051] like figure 1 As shown in A and C, the methylation level of the MT-ND6 gene was significantly increased in the peripheral blood leukocytes of type 2 diabetic human and in the liver of obese mice. like figure 2 As shown in C and D, linear correlation analysis showed that the methylation level of MT-ND6 gene in human peripheral blood leukocytes was positively correlated with HOMA-IR and glycosylated hemoglobin content, suggesting that methylation of MT-ND6 could serve as a biomarker of insulin resistance thing. Since insulin resistance is the pathological basis and core link of various metabolic diseases such as obesity and type 2 diabetes, the methylation of MT-ND6 gene can be used as an early clinical screening for metabolic syndrome and its co...
Embodiment 2
[0053] Methylation of MT-ND6 gene can be used as a biomarker for early clinical screening, diagnosis and prognosis of hyperlipidemia (or hyperlipidemia)
[0054] Elevated serum triglyceride levels are one of the most important features of hyperlipidemia (or hyperlipidemia), such as figure 2 As shown in B, the methylation modification level of MT-ND6 gene in human peripheral blood leukocytes is linearly positively correlated with serum triglyceride level, suggesting that the methylation of MT-ND6 gene can be used as a function of hyperlipidemia (or hyperlipidemia) Biomarkers for early clinical screening, diagnosis and prognosis.
Embodiment 3
[0056] The expression level of MT-ND6 can be used as a biomarker for early clinical screening, diagnosis and prognosis of hyperlipidemia (or hyperlipidemia), obesity, type 2 diabetes and metabolic syndrome and its complications
[0057] like figure 1 As shown in B and D, the mRNA expression level of the MT-ND6 gene was reduced in type 2 diabetic and obese mice, while as figure 2 As shown in A, the methylation of MT-ND6 gene in human peripheral blood leukocytes is linearly negatively correlated with its mRNA expression. Since the methylation level of MT-ND6 was positively correlated with serum triglyceride, HOMA-IR and glycosylated hemoglobin ( figure 2 B-D), it can be seen that the mRNA expression of MT-ND6 gene is negatively correlated with serum triglyceride, HOMA-IR and glycosylated hemoglobin levels, suggesting that the expression level of MT-ND6 (mRNA and protein levels) can be used as a function of hyperlipidemia (or hyperlipidemia). biomarkers for early clinical scr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com